Table I.

Patient Diagnoses, Gender, Median Age at Diagnosis and Median Number of Therapies

	Number of Patients*	Male	Female	Median Age at Diagnosis (range) (in years)	Median Therapies (range) (in years)
Total	142	77	65	55.7 (9.4-81.6)	3 (1-11)
Colorectal	20	11	9	55.3 (33.1-79.9)	4 (2-9)
Other Gastrointestinal	17	12	5	54.0 (9.4-72.9)	2 (1-10)
Prostate	17	17	0	60.3 (52.0-75.2)	3 (2-8)
Breast	12	1	11	44.9 (28.0-57.3)	7 (3-11)
Non-small-cell Lung	13	9	4	63.9 (41.6-81.6)	3 (1-4)
Ovarian	11	0	11	59.8 (44.2-75.3)	4 (2-9)
Pancreatic	9	6	3	61.0 (31.7-79.6)	1 (1-4)
Gynecological	8	0	8	39.6 (24.4-69.7)	1.5 (1-3)
Head and Neck	8	6	2	51.9 (45.3-72.3)	2 (1-8)
Skin	7	6	1	48.2 (32.0-73.3)	2 (1-3)
Other	6	1	5	52.4 (39.5-62.7)	2 (1-5)
Small-cell Lung	4	0	4	55.9 (50.0-66.2)	2.5 (2-3)
Genitourinary	3	3	0	53.2 (19.5-66.6)	3 (2-4)
Sarcoma	3	2	1	66.7 (29.9-78.0)	2 (1-3)
Thoracic	3	2	1	37.9 (19.6-60.1)	1 (1-4)
Adrenal	1	1	0	54.0 (54.0-54.0)	1 (1-1)

"Other" include: unknown primary (n=2), carcinoma (n=1), eccrine sweat gland (n=1), leiomyosarcoma (n=1), occular melanoma (n=1).

*Does not include patients that were censored from analysis.